A 29-amino acid synthetic peptide representing the active fragment of native GHRH. It is utilized in research settings to explore the mechanisms of growth hormone synthesis and the regulatory feedback loops of the hypothalamic-pituitary axis. For research use only. Not for human consumption.
Sermorelin is a synthetic research peptide corresponding to the first 29 amino acids of native growth hormone–releasing hormone (GHRH 1–44), a region recognized as the peptide’s primary biologically active sequence. In experimental settings, Sermorelin interacts with GHRH receptors located on pituitary somatotroph cells and initiates intracellular signaling through adenylate cyclase activation and cAMP-dependent pathways.
Preclinical studies commonly employ Sermorelin to examine mechanisms of growth hormone synthesis and secretion, as well as regulatory processes within the hypothalamic–pituitary axis. Its defined structure and receptor specificity make it a useful research tool for investigating endocrine feedback loops, somatotropic signaling pathways, and peptide-mediated regulation of pituitary function under controlled laboratory conditions.
For research use only. Not for human consumption.
References
Thorner MO, et al. Journal of Clinical Endocrinology & Metabolism. 1986;63(3):638–643.
Frohman LA, et al. Endocrine Reviews. 2001;22(6):606–648.
Walker RF, et al. Endocrinology. 1990;126(3):1527–1532.